New York, NY, March 21, 2022 — HITLAB is pleased to announce that two of our innovators have been showcased in Forbes for their continued vision to create a better and healthier every day for every woman around the globe.
Featured in the article are seven female leaders changing the narrative around inclusivity and accessibility of the healthcare industry, from supporting LGBTQ+ communities and neurodiverse patients to women who have experienced pregnancy loss or abortion, to patients suffering from hormonal imbalance.
"I wanted to build a company that authentically engages local communities, women, and girls living in the most challenging settings in the world to build quality digital solutions to address the most stigmatized sexual and reproductive health issues."
“Our primary customers are females who are 18-35 years old, single and either in the university or post-secondary school, women who have just started their first job, and married women who have just had their first or second child.”
About HITLAB
Established in 1998, HITLAB is a leading evidence-based, digital health efficacy teaching and testing center specializing in the delivery of world-class digital health innovation research. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges across the globe. HITLAB works with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.
Explore Recent Posts
We are thrilled to announce a significant collaboration reflective of our ongoing
commitment to improving healthcare outcomes through innovation and user-centered
design. HITLAB is joining forces with Birthvue, an emerging startup determined to transform
perinatal care and pain management in the delivery rooms.
Patient data is the backbone of all clinical trials. However, trial subject recruitment, engagement and data collection are very costly activities. According to the Deloitte Center for Health, roughly a third of a clinical trial’s total costs go toward patient recruitment alone. The rise of remote monitoring tools in the post pandemic era, such as smart packaging, wearables, and other technology, can help focus and contain trial efforts for individual patients, while reducing costs, and diversifying trial patient samples for more effective drug development.
The HITLAB Breakthrough Alliance is holding a ‘Call for Applications’ for its annual Fall 2023 Breakthrough Alliance Challenge. They are looking for the world’s most innovative developing and early commercial digital health technologies that solve significant gaps in healthcare. The challenge is open to all new and innovative solutions across the healthcare spectrum.
